Tis the season for sickness in South Florida."I see him very congestion, very gloomy," said Jamie Jorge, of Coral ...

The American Academy of Pediatrics has issued updated recommendations for RSV prevention in infants and high-risk young children.

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

Respiratory syncytial virus infection in adults aged 45 years or older is significantly associated with a higher 1-year risk ...

Food and Drug Administration officials have opened a safety review of two injectable drugs used to protect babies and ...

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children.

As an FDA official said that the agency has evidence that links COVID vaccines to the deaths of at least 10 children, the U.S ...

Among adults older adults, a respiratory syncytial virus (RSV) infection increases the risk of cardiovascular events over the ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

COVID-19, RSV, and influenza immunizations show continued safety and substantial effectiveness against hospitalization across various populations.

In this morning's Pharmalittle roundup, we're reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...